We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+24.43%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.3B
AUM Growth
-$343M
Cap. Flow
-$2.51B
Cap. Flow %
-18.9%
Top 10 Hldgs %
48.31%
Holding
117
New
19
Increased
28
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$737M
2
SPGI icon
S&P Global
SPGI
+$177M
3
SHW icon
Sherwin-Williams
SHW
+$160M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$145M
5
GG
Goldcorp Inc
GG
+$139M

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$616M
2
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$370M
3
EQIX icon
Equinix
EQIX
+$283M
4
META icon
Meta Platforms (Facebook)
META
+$194M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$193M

Sector Composition

Rank Sector Weight
1 Healthcare 27.15%
2 Technology 20.49%
3 Communication Services 16.9%
4 Industrials 6.58%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SE icon
26
Sea Limited
SE
$70.4B
$163M 1.22%
+6,920,000
New +$121M
AZN icon
27
AstraZeneca
AZN
$250B
$157M 1.18%
1,942,500
– –
CI icon
28
Cigna
CI
$71.5B
$152M 1.14%
945,000
-110,000
-10% -$20.1M
WCG
29
DELISTED
Wellcare Health Plans, Inc.
WCG
$151M 1.14%
+560,000
New +$145M
GG
30
DELISTED
Goldcorp Inc
GG
$148M 1.12%
+12,960,000
New +$139M
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
$134M 1.01%
5,500,000
-250,000
-4% -$5.2M
ARRS
32
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$118M 0.89%
3,745,000
+165,000
+5% +$5.17M
ZGNX
33
DELISTED
Zogenix, Inc.
ZGNX
$113M 0.85%
2,050,500
– –
XLRN
34
DELISTED
Acceleron Pharma
XLRN
$111M 0.83%
2,375,000
+275,000
+13% +$12.1M
LBTYK icon
35
Liberty Global Class C
LBTYK
$3.51B
$104M 0.78%
4,308,106
-629,096
-13% -$14.9M
MYOK
36
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$101M 0.76%
1,950,278
+350,000
+22% +$16.1M
FOX icon
37
Fox Class B
FOX
$21.9B
$101M 0.76%
+2,807,431
New +$107M
LBTYA icon
38
Liberty Global Class A
LBTYA
$3.61B
$98.4M 0.74%
3,949,553
-2,022,884
-34% -$49.4M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$95.4M 0.72%
600,000
+200,000
+50% +$29M
ONCE
40
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$93.4M 0.7%
+820,000
New +$60.3M
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$384M
$89.8M 0.68%
940,000
+15,000
+2% +$1.35M
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$88M 0.66%
1,200,000
-100,000
-8% -$6.8M
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
$79.4M 0.6%
1,500,000
+50,000
+3% +$2.46M
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.68B
$77.5M 0.58%
650,000
+10,000
+2% +$1.29M
BABA icon
45
Alibaba
BABA
$308B
$75.7M 0.57%
415,000
-635,000
-60% -$107M
EXEL icon
46
Exelixis
EXEL
$14.3B
$71.4M 0.54%
3,000,000
+1,000,000
+50% +$22.8M
AMRN
47
Amarin Corp
AMRN
$304M
$67.5M 0.51%
162,500
-12,500
-7% -$4.51M
RETA
48
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$64.1M 0.48%
750,000
+50,000
+7% +$4.15M
GRFS
49
Grifois
GRFS
$5.4B
$58.8M 0.44%
2,926,352
+545,233
+23% +$10.4M
IOVA icon
50
Iovance Biotherapeutics
IOVA
$1.94B
$54.4M 0.41%
5,725,000
– –
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Farallon Capital Management held 117 positions worth $13.3B, down 2.5% from $13.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $2.51B in Q1 2019, closing 22 positions and reducing 28 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $616M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Celgene Corp worth $795M.

  • Farallon Capital Management's largest Q1 2019 buy was Celgene Corp: 8,430,000 shares worth $795M.
  • Farallon Capital Management added most to Red Hat Inc in Q1 2019, an estimated $116M increase.
  • Farallon Capital Management's biggest Q1 2019 reduction was Equinix, cutting an estimated $283M.
  • Farallon Capital Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $616M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $13.3B portfolio in Q1 2019.
  • Farallon Capital Management opened 19 new positions and closed 22 in Q1 2019.
  • Farallon Capital Management's portfolio value fell 2.5% quarter-over-quarter to $13.3B.

Based on Farallon Capital Management's 13F filing for Q1 2019, filed 15 May 2019.